Therapiva is a leading generic pharmaceutical company backed by a strong
and innovative R&D facility and a world-class API manufacturing facility. It has a robust product
portfolio spread across various therapeutic areas, capable of handling new, complex and hazardous
reactions. Therapiva supplies NCEs, cGMP intermediates and KSMs to global innovators. It is equipped
with flexible, versatile and advanced infrastructure, tailored to fit any complex chemistry molecules
churning out of Innovator’s development pipelines.
The manufacturing facilities comply with all regulatory guidelines and requirements of current Good Manufacturing Practices (cGMP) and are successfully inspected/approved by health and regulatory agencies.
To become a respectable company in the pharmaceutical industry, lead by R&D and innovation as the main focus.